30th Annual Clinical Update for the Comprehensive Ophthalmologist
The Texas Tech University Health Sciences Center (TTUHSC) Department of Ophthalmology and Visual Sciences will host the 30th Annual Clinical Update for the Comprehensive Ophthalmologist from 7:30 a.m. to 5:15 p.m. June 28 at the Overton Hotel and Conference Center Horizon Ballroom, 2322 Mac Davis Lane.
The purpose of the conference is to provide ophthalmologists with current and emerging surgical techniques, treatments and medications for diseases and disorders of the eye. Learning objectives will include: recognizing and recommending further evaluation and treatment options for patients, including when to refer to other specialists in ophthalmology and developing patient-centered, evidence-based evaluation and treatment plans.
Presentations and speakers include:
- Clinical Research: Why Me, Why Now?
Wade A. Graham, M.D. - Endophthalmitis — What’s New Locally and Globally
Mark T. Goulas, M.D. - Cornea and Refractive Surgery, Transepithelial Phototherapeutic Keratectomy Guided
by Optical Coherence Tomography Imaging
Sloan W. Rush, M.D. - New Options for the Management of Corneal Ectasia
Walter Beebee, M.D. - Amniotic Membrane: The Cover Up
William W. Yang, M.D. - Retina, Vitritis in a Healthy 18-Year-Old Male: What’s Next?
Michel J. Shami, M.D. - Management of Retained Lens Fragments Following Cataract Extraction
Lina M. Marouf, M.D. - Conclusions from the Comparison of Age-related Macular Degeneration Treatments Trial
Joel George, M.D. - Mechanism of Macular Hole Closure
Sunil S. Patel, M.D. - Current Concepts in the Management of Oculoplastics Disorders
Jorge Corona, M.D. - Emerging Trends and Paradigm Shifts in Glaucoma Management
Craig J. Chaya, M.D. and John Kim, M.D. - Ethics, Collegial Relationships and Communication
George R. Beauchamp, M.D., Charles Cohn, M.D., Prashanthi Giridhar, M.D., and Jonathan Kaufman, M.D. - Update on Medial Uses of Botulinum Toxin in Ophthalmology
Kenn Freedman, M.D., Ph.D. - Evaluation and Management of Optic Disc Edema
James Khu, M.D. - An Emerging Framework for Target Therapy of Uveal Melanoma
David A. Lewis, M.D. - What’s New in Pediatric Ophthalmology?
Curt Cockings, M.D.
The conference is sponsored by the TTUHSC Department of Ophthalmology and Visual Sciences and the Office of Continuing Medical Education. For more information, call Myra Jones, TTUHSC Office of Continuing Medical Education, at (806) 743-2929 or email myra.jones@ttuhsc.edu or cme@ttuhsc.edu
For more breaking news and experts, follow @ttuhscnews on Twitter.
Related Stories
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing
Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.
TTUHSC School of Nursing to Celebrate New YWCA Location
Community members in central Lubbock now have access to health care services and prenatal programs at one location inside the YWCA.
Recent Stories
New Permian Basin Chair Seeks to Develop International Hub for Rural Psychiatry
Rajendra Badgaiyan, M.D., joined the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine in November as a professor and Department of Psychiatry chair at the Permian Basin campus.
The ARRIVE Program: Offering a Brighter Future for the IDD Community
The ARRIVE Program provides a supported work context within the TTUHSC Occupational Therapy Department (OTD) for young adults with IDD to gain necessary skills.
Study Focuses on Resistance to Androgen Receptor-Targeted Therapy in Advanced Prostate Cancer
A TTUHSC research team led by Srinivas Nandana, Ph.D., and Manisha Tripathi, Ph.D., from the TTUHSC School of Medicine recently completed a study that focused on uncovering the mechanisms that drive the progression of prostate cancer.